Developing a treatment for Alzheimer's in the world of AI with Sacha Schermerhorn

from Power to the Patients · host Brandon Li

Learn about clinical trial design for small molecule therapies using biomarkers in Alzheimer's research and AI in drug development. Brandon Li talks with Sacha Schermerhorn, Founder and CEO of Babylon Biosciences. They discuss why the industry needs to rethink disease pathology, how to recruit elite talent out of retirement, and the role of fine-tuned AI models in predicting clinical outcomes for patients.

Episode metadata supplied by the publisher feed · Published Jul 7, 2026

Embed this episode

Attribution link and audio player

Ready to play

Developing a treatment for Alzheimer's in the world of AI with Sacha Schermerhorn

0:00 33:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

How to End Heart Disease with Dr. Fuhrman

Feb 11, 2026 ·45m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Power to the Patients?

This episode is 33 minutes long.

When was this Power to the Patients episode published?

This episode was published on July 7, 2026.

Can I download this Power to the Patients episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!